SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-23-116383
Filing Date
2023-11-09
Accepted
2023-11-09 17:23:45
Documents
1
Period of Report
2023-09-30
Effectiveness Date
2023-11-09

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tm2330390-1_nt10q.htm NT 10-Q 29807
  Complete submission text file 0001104659-23-116383.txt   30952
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 231393868
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences